Aurobindo Pharma, an Indian private pharmaceutical company, informed that it has got tentative sanction from US Food & Drug Administration (USFDA) to make and sell fixed dosed combination Abacavir Sulfate/ Lamivudine Tablets.
The company has been allowed to manufacture the drugs in the strengths of 60/30 mg.
Abacavir sulfate tablets are indicated for the treatment of HIV infection in adults and children 3 months of age or older.